Rei Mimoto

453 total citations
15 papers, 380 citations indexed

About

Rei Mimoto is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Rei Mimoto has authored 15 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Rei Mimoto's work include Cancer Cells and Metastasis (6 papers), Cancer Risks and Factors (2 papers) and Neuroblastoma Research and Treatments (2 papers). Rei Mimoto is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Cancer Risks and Factors (2 papers) and Neuroblastoma Research and Treatments (2 papers). Rei Mimoto collaborates with scholars based in Japan and United States. Rei Mimoto's co-authors include Kiyotsugu Yoshida, Shinichi Hirooka, Naoe Taira, Yoshio Miki, Hiroshi Takeyama, Morito Kurata, Tomoko Yamaguchi, Masanobu Kitagawa, Ken Uchida and Masataka Okabe and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Oncogene.

In The Last Decade

Rei Mimoto

14 papers receiving 378 citations

Peers

Rei Mimoto

ONCOL

PHEOH

NEURO

Wouter Van Loocke Belgium

Liliana H. Mochmann Germany

Rachael A. Papa Australia

Agnieszka A. Wendorff United States

Julie Ross Canada

Mariana L. Oliveira Portugal

Fotini Vogiatzi Germany

J Schwaller Switzerland

Valentina Agnusdei Italy

Katie L. Kathrein United States

Wouter Van Loocke Belgium

Rei Mimoto

309 ×1.3

89 ×0.7

ONCOL

153 ×2.0

97 ×1.4

PHEOH

27 ×0.5

NEURO

Citations per year, relative to Rei Mimoto Rei Mimoto (= 1×) peers Wouter Van Loocke

Countries citing papers authored by Rei Mimoto

Since Specialization

Citations

This map shows the geographic impact of Rei Mimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rei Mimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rei Mimoto more than expected).

Fields of papers citing papers by Rei Mimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rei Mimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rei Mimoto. The network helps show where Rei Mimoto may publish in the future.

Co-authorship network of co-authors of Rei Mimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Rei Mimoto. A scholar is included among the top collaborators of Rei Mimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rei Mimoto. Rei Mimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Mimoto, Rei, Satomi Yogosawa, Atsushi Fushimi, et al.. (2019). Clinical implications of drug-screening assay for recurrent metastatic hormone receptor-positive, human epidermal receptor 2-negative breast cancer using conditionally reprogrammed cells. Scientific Reports. 9(1). 13405–13405. 6 indexed citations

Uchida, Kazutaka, et al.. (2018). Abstract P3-10-18: Factors associated with mammographic density in Japanese women. Cancer Research. 78(4_Supplement). P3–10.

Mimoto, Rei, Atsushi Fushimi, Takashi Kazama, Hiroko Nogi, & Hiroshi Takeyama. (2018). Conditional Reprogramming Cells Are Novel Tools for Drug Response Assay and the Development of Personalized Medicine in Luminal-B Breast Cancer. Journal of the American College of Surgeons. 227(4). e79–e79. 4 indexed citations

Nogi, Hiroko, Ken Uchida, Rei Mimoto, et al.. (2017). Long-Term Follow-Up of Node-Negative Breast Cancer Patients Evaluated via Sentinel Node Biopsy After Neoadjuvant Chemotherapy. Clinical Breast Cancer. 17(8). 644–649. 18 indexed citations

Ito, Daisuke, Satomi Yogosawa, Rei Mimoto, et al.. (2017). Dual‐specificity tyrosine‐regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer. Cancer Science. 108(8). 1565–1573. 31 indexed citations

Mimoto, Rei, et al.. (2017). Downregulation of dual‐specificity tyrosine‐regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin‐dependent kinase 14 expression in breast cancer. Cancer Science. 109(2). 363–372. 30 indexed citations

Mimoto, Rei, Naoe Taira Nihira, Shinichi Hirooka, Hiroshi Takeyama, & Kiyotsugu Yoshida. (2016). Diminished DYRK2 sensitizes hormone receptor-positive breast cancer to everolimus by the escape from degrading mTOR. Cancer Letters. 384. 27–38. 20 indexed citations

Mimoto, Rei, et al.. (2016). Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer. Oncogene. 36(13). 1862–1872. 30 indexed citations

Yamaguchi, Noriko, Rei Mimoto, Nozomu Yanaihara, et al.. (2015). DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma. Tumor Biology. 36(8). 5913–5923. 32 indexed citations

10.

Mimoto, Rei, Tadashi Kobayashi, Kumiko Kato, et al.. (2014). Clinical relevance and low tumor-initiating properties of oligometastatic breast cancer in pulmonary metastasectomy. Breast Cancer Research and Treatment. 147(2). 317–324. 6 indexed citations

11.

Mimoto, Rei, Naoe Taira, Hiroyuki Takahashi, et al.. (2013). DYRK2 controls the epithelial–mesenchymal transition in breast cancer by degrading Snail. Cancer Letters. 339(2). 214–225. 63 indexed citations

12.

Uchida, Ken, Hiroko Nogi, Kumiko Kato, et al.. (2013). Breast cancer screening and the changing population pyramid of Japan. Breast Cancer. 22(2). 172–176. 27 indexed citations

13.

Taira, Naoe, Rei Mimoto, Morito Kurata, et al.. (2012). DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells. Journal of Clinical Investigation. 122(3). 859–872. 111 indexed citations

14.

Mimoto, Rei & Tadashi Kobayashi. (2012). [Individualized treatment of breast cancer chemotherapy].. PubMed. 70 Suppl 7. 601–5. 1 indexed citations

15.

Taira, Naoe, Rei Mimoto, Yoshio Miki, & Kiyotsugu Yoshida. (2012). Abstract 3060: DYRK2-mediated phosphorylation of c-Jun and c-Myc is requisite for proper control of the G1/S transition. Cancer Research. 72(8_Supplement). 3060–3060. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact